Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
1.95M
-
Shares change
-
-40.2K
-
Total reported value, excl. options
-
$3.42M
-
Value change
-
-$82.2K
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$1.83
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q2 2020
5 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q2 2020.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.95M shares
of 45.5M outstanding shares and own 4.29% of the company stock.
Largest 5 shareholders include Knoll Capital Management, LP (1.74M shares), Wildcat Capital Management, LLC (131K shares), Phoenix Holdings Ltd. (37.4K shares), WEDBUSH SECURITIES INC (30K shares), and UBS Group AG (10.4K shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.